Methods and compositions for determining the purity of chemically synthesized nucleic acids
This application describes an antibody that specifically binds to a synthetic oligomer (e.g., an oligonucleotide or oligopeptide) having a organic protecting group covalently bound thereto, which antibody does not bind to that synthetic oligomer when the organic protecting group is not covalently bound thereto. Methods of making and using such antibodies are also disclosed, along with cells for making such antibodies and articles carrying immobilized oligomers that can be used in assay procedures with such antibodies.
1. A method of using an oligonucleotide array and compensating for insufficient deprotection or insufficient elongation of oligonucleotides on said array, comprising the steps of:
(a) providing a substrate having a plurality of different oligonucleotides immobilized thereon, with said different oligonucleotides immobilized in different separate and discrete locations on said substrate;
(b) providing indicia associated with said array, said indicia recording the presence of insufficient deprotection or insufficient elongation of at least one oligonucleotide, said at least one oligonucleotide located in a separate and discrete locations on said array;
(c) providing a test compound;
(d) detecting the binding of said test compound to at least one of said plurality of different oligonucleotides; and then
(d) determining the degree of binding of said test compound to said oligonucleotide from (i) said detected binding and (ii) said indicia recording the presence of insufficient deprotection or insufficient elongation, so that said insufficient deprotection or insufficient elongation is compensated for during said determining step.
2. A method according to claim 1 , wherein said test compound is a protein, peptide, or oligonucleotide.
3. A method according to claim 1 , wherein said test compound is mRNA.
4. A method according to claim 1 , wherein said determining step is carried out by generating a color indication of degree of binding.
5. A method according to claim 1 , wherein said determining step is carried out by generating a numeric indication of degree of binding.
6. A method according to claim 1 , wherein said degree of binding is binding affinity, binding amount, or both binding affinity and binding amount.
7. A method of using an oligonucleotide array while compensating for insufficient deprotection or insufficient elongation of oligonucleotides on said array, said method comprising the steps of:
(a) providing a substrate having a plurality of different oligonucleotides immobilized thereon, with said different oligonucleotides immobilized in different separate and discrete locations on said substrate;
(b) providing indicia associated with said array, said indicia recording the presence of insufficient deprotection or insufficient elongation of at least one oligonucleotide, said at least one oligonucleotide located in a separate and discrete locations on said array;
(c) providing a test compound;
(d) contacting said test compound to said array;
(d) deleting from analysis said at least one oligonucleotide in a separate and discrete location having insufficient deprotection, with binding of said test compound to said array being detected with the remaining oligonucleotides in separate and discrete locations that have not been deleted from analysis; and then
(d) detecting the binding of said test compound to said remaining oligonucleotides in separate and discrete locations in said array.
8. A method according to claim 7 , wherein said test compound is a protein, peptide, or oligonucleotide.
9. A method according to claim 7 , wherein said test compound is mRNA.
10. A method according to claim 7 , wherein said detecting step is carried out by generating a color indication of binding.
11. A method according to claim 7 , wherein said detecting step is carried out by generating a numeric indication of binding.